Hot High Dividend Stocks To Invest In 2014

One way to think about the market is in terms of money flows between assets with different risk characteristics. When times are good, money moves out of bonds, which are perceived as safe because bondholders take priority in liquidation proceeds, and into stocks, which are riskier because their owners are last in line. When times are bad, it's the opposite.

The same can be said within asset classes as well. Riskier bonds, known as junk bonds, are more popular when the economy is perceived to be safe, while safer stocks (generally those that pay high dividend yields) demand higher premiums when times are tough. With that in mind, it should be no surprise that the latter are trading for higher multiples than ever.

The conversation about a "dividend bubble" began in earnest at the beginning of last year. As my colleague Morgan Housel said in February 2012, "there's an argument to make that, just as investors ran blindly into subprime bonds five years ago in search of yield, they're running blindly, carelessly into dividend stocks today."

Hot High Dividend Stocks To Invest In 2014: Arena Pharmaceuticals Inc.(ARNA)

Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company?s clinical development programs include lorcaserin that has completed two pivotal Phase III clinical trials for the treatment of weight management, including weight loss and maintenance of weight loss; and APD811, which is under Phase I clinical trial for the treatment of pulmonary arterial hypertension. Its preclinical development programs include APD334, for the treatment of autoimmune diseases, including multiple sclerosis and rheumatoid arthritis. The company also researches and develops cannabinoid, receptor agonists for the treatment of osteoarthritis and pain; and GPR119 agonists for the treatment of type 2 diabetes. Its other development programs, which had completed Phase I clinical trial include APD597 for th e treatment of type II diabetes; APD916 for the treatment of narcolepsy and cataplexy; and APD791 for the treatment of arterial thrombosis. In addition, the company provides manufacturing services. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

Advisors' Opinion:

• [By TheStreet Staff]

   The U.S. commercial launch of Arena Pharmaceuticals (ARNA) and Eisai's weight-loss pill Belviq will be a major disappointment. Belviq will also fail to receive European approval.

Hot High Dividend Stocks To Invest In 2014: AMCIL Ltd(AMH.AX)

Amcil Limited is a publicly owned investment manager. The firm primarily manages separate client focused equity portfolios for its clients. It invests in the public equity markets of Australia. The firm invests in growth and value stocks of large cap and small cap companies to create its portfolios. It invests in companies from media, technology, communications, and entertainment sectors. Amcil Limited was founded in 1996 and is based in Melbourne, Australia.

Top Canadian Stocks To Own For 2014: Real Goods Solar Inc.(RSOL)

Real Goods Solar, Inc. operates as a residential and commercial solar energy integrator primarily in California and Colorado. The company provides engineering, procurement, and construction services. It offers various turnkey solar energy services, including design, procurement, permitting, build-out, grid connection, financing referrals, and warranty and customer satisfaction services. The company installs residential and small commercial systems that range between 3 kilowatts and 1 megawatt output. It also engages in the retail sale of renewable energy products. The company was founded in 1978 and is based in Louisville, Colorado.

Advisors' Opinion:

• [By Matthews]

  Real Goods Solar, Inc.(NASDAQ: RSOL) closing price in the stock market Tuesday, Jan. 3, was $1.50. RSOL is trading 8.97% above its 50 day moving average and -25.21% below its 200 day moving average. RSOL is -50.98% below its 52-week high of $3.06 and 51.52% above its 52-week low of $0.99. RSOL‘s PE ratio is N/A and its market cap is $26.93M.

  Real Goods Solar, Inc. operates as a residential and commercial solar energy integrator primarily in California and Colorado.